Together with their previous study [30], they estimated that BRCA2 mutations accounted for 6% of pancreatic cancers in high-risk families for pancreatic cancer and 6% of families fulfilled the criteria of familial pancreatic cancer. The gene discussed is BRCA2; the disease is pancreatic neoplasm.